Spot Trading’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.32M Buy
2,988
+1,745
+140% +$2.44M 0.09% 260
2017
Q2
$1.69M Buy
1,243
+865
+229% +$1.04M 0.03% 747
2017
Q1
$445K Sell
378
-186
-33% -$190K 0.01% 1319
2016
Q4
$450K Sell
564
-965
-63% -$766K 0.01% 1478
2016
Q3
$1.34M Buy
1,529
+834
+120% +$604K 0.03% 883
2016
Q2
$390K Sell
695
-8
-1% -$4.53K 0.01% 1791
2016
Q1
$387K Sell
703
-92
-12% -$56.5K 0.01% 1764
2015
Q4
$661K Buy
795
+602
+312% +$601K 0.01% 1726
2015
Q3
$214K Buy
193
+93
+93% +$170K ﹤0.01% 2654
2015
Q2
$219K Sell
100
-39
-28% -$79.4K ﹤0.01% 2654
2015
Q1
$217K Buy
139
+62
+81% +$81.8K ﹤0.01% 2692
2014
Q4
$92K Buy
+77
New +$51.5K ﹤0.01% 3266

Other funds holding BLUE

Spot Trading's BLUE Position: Q3 2017 in Review

Spot Trading increased its bluebird bio (BLUE) stake by 36% in Q3 2017, buying an estimated $110K and bringing the position to 300 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #1598.

Spot Trading first reported a position in BLUE in Q3 2014 and has held it in 11 quarters since. The position peaked at $844K in Q3 2016. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Spot Trading held 300 shares of bluebird bio worth $535K as of Q3 2017.
  • Spot Trading bought 79 bluebird bio shares in Q3 2017, an estimated $110K.
  • bluebird bio made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1598 holding.
  • Spot Trading first reported a position in bluebird bio in Q3 2014 and has held it in 11 quarters since.
  • Spot Trading's bluebird bio position peaked at $844K in Q3 2016.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.